NCT06493890 Validation of the Dutch Translation of the Prosthesis Evaluation Questionnaire
| NCT ID | NCT06493890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Groningen |
| Condition | Validation Studies |
| Study Type | OBSERVATIONAL |
| Enrollment | 84 participants |
| Start Date | 2022-11-01 |
| Primary Completion | 2024-07-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 84 participants in total. It began in 2022-11-01 with a primary completion date of 2024-07-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our research is to be able to use the questionnaire 'Prosthesis Evaluation Questionnaire' (PEQ) in Dutch. The PEQ is a validated and reliable questionnaire for research into the quality of life in adults with a lower limb prosthesis. The research consists of two phases. The first phase is the translation of the PEQ and the second phase is the validation of this questionnaire. To validate the questionnaire, we want to include 84 participants who have to complete questionnaires three times within a period of three months.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * Unilateral lower limb amputation at ankle level or higher * Mastering Dutch language Exclusion Criteria: * Children * Bilateral or foot amputations
Contact & Investigator
Corry K Sluis, Prof
STUDY CHAIR
University Medical Center Groningen
Frequently Asked Questions
Who can join the NCT06493890 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Validation Studies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06493890 currently recruiting?
Yes, NCT06493890 is actively recruiting participants. Contact the research team at m.a.hulshof@umcg.nl for enrollment information.
Where is the NCT06493890 trial being conducted?
This trial is being conducted at Groningen, Netherlands.
Who is sponsoring the NCT06493890 clinical trial?
NCT06493890 is sponsored by University Medical Center Groningen. The principal investigator is Corry K Sluis, Prof at University Medical Center Groningen. The trial plans to enroll 84 participants.